Case Study

Rapid Startup and Early Enrollment Completion for a GLP-1 Study

Tekton delivered a Phase 3 GLP-1 medication research study at its Moore, Oklahoma, site. The site moved quickly from startup to enrollment while maintaining a focused, coordinated approach throughout the study.

  • Enrollment goal achieved 3 months early
  • 1-day regulatory turnaround
  • First participant visit <24 hours after activation

Talk to Tekton

obesity-research

About This Study

TRIAL
Phase 3 GLP-1 medication research study

SITE LOCATION
Moore, OK

Partner With Tekton

Join leading Sponsors and CROs that trust Tekton's sites to support their most important clinical trials.

Complete the form on this page or email to discuss your protocol, target population, timelines, and site needs.

Submit Your Information